Study of TFC-003 for open-angle glaucoma or high eye pressure
Part of Eyes & vision clinical trials.
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have primary open-angle glaucoma or high eye pressure (ocular hypertension)
- You have used or are using at least two types of glaucoma eye drops (like dorzolamide and a beta-blocker), or your eye pressure is not well controlled with current treatment
- You have not used certain glaucoma medications for a specific washout period before starting the study (different times for different drugs)
- Your eye pressure measures 21 mmHg or higher at the start of the study
- You do not have severe eye disease, asthma, certain heart conditions, or other serious health issues that would interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This trial tests a new medicine called HUC3-637 for people with primary open-angle glaucoma or ocular hypertension. It aims to see if it safely lowers eye pressure.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This study tests a combination eye medication to lower eye pressure in people who have high pressure in their eyes (ocular hypertension) or a specific type of glaucoma (primary open-angle glaucoma). The goal is to see if it's safe and works better than current options.
This study compares a special contact lens that measures eye pressure with standard eye-pressure testing. It may help people with glaucoma or ocular hypertension by improving how pressure is monitored.
Hear when a new Ocular Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.